We offer a 16 week Ketamine Assisted Psychotherapy Program,

with a total of 8 medicine sessions, every other week, rotating the opposite week with integration therapy sessions.

​

Ketamine has shown to have a beneficial aftereffect period lasting 2 weeks post medicine,

and here's why:

​

Understanding the Two-Week Beneficial Aftereffect of Ketamine

​

Ketamine, originally developed as an anesthetic, has garnered significant attention in recent years for its potential therapeutic effects, particularly in the treatment of depression and other mood disorders. One intriguing aspect of ketamine treatment is the observed two-week beneficial aftereffect, where relief from symptoms persists well beyond the immediate effects of the drug. Let's delve into this phenomenon to understand its significance and implications for mental health treatment.

​

1. Immediate Effects of Ketamine: Ketamine works by blocking NMDA receptors in the brain, leading to a rapid increase in certain neurotransmitters like glutamate. This surge in neurotransmitter activity is believed to promote the growth of new synaptic connections and enhance communication between neurons. As a result, patients often experience a rapid reduction in depressive symptoms, sometimes within hours of receiving ketamine.

​

2. Two-Week Aftereffect: What sets ketamine apart from traditional antidepressants is its ability to induce a sustained antidepressant effect that lasts beyond the drug's immediate presence in the body. Research suggests that ketamine triggers a cascade of molecular and cellular changes in the brain, including the activation of certain signaling pathways and the expression of specific genes associated with synaptic plasticity and resilience.

​

3. Neuroplasticity and Synaptic Remodeling: Ketamine's ability to enhance neuroplasticity—the brain's capacity to reorganize and form new neural connections—is believed to underlie its prolonged antidepressant effects. By promoting synaptic remodeling and strengthening connections between neurons, ketamine may help restore healthy brain function in individuals with mood disorders.

​

4. Impact on Mood Circuitry: Ketamine's effects extend beyond neurotransmitter modulation to influence broader mood-regulating circuits in the brain. Functional imaging studies have shown alterations in the activity of regions involved in emotion processing and regulation following ketamine treatment, suggesting a normalization of dysfunctional neural circuits implicated in depression.

​

5. Potential Mechanisms: Several mechanisms have been proposed to explain the sustained antidepressant effects of ketamine, including:

​

• Increased synaptogenesis and dendritic spine formation.

​

• Enhanced neurotrophic factor expression, such as brain-derived neurotrophic factor (BDNF), which supports neuronal growth and survival.

​

• Modulation of inflammatory pathways implicated in mood disorders.

​

• Restoration of the balance between excitatory and inhibitory neurotransmission.

​

6. Clinical Implications: Understanding the two-week beneficial aftereffect of ketamine holds significant implications for the treatment of depression and related mood disorders. By providing rapid relief and fostering sustained improvement, ketamine therapy offers a promising alternative for individuals who have not responded to traditional antidepressants or psychotherapy.

​

7. Challenges and Future Directions: Despite its potential, ketamine therapy is not without challenges, including the risk of abuse, dissociative side effects, and the need for repeated administrations to maintain efficacy. Ongoing research aims to optimize ketamine treatment protocols, identify biomarkers predictive of treatment response, and develop novel pharmacological agents that replicate its therapeutic effects with improved safety and tolerability.

​

In conclusion, the two-week beneficial aftereffect of ketamine represents a fascinating phenomenon in the field of psychiatry, offering insights into the neurobiological mechanisms underlying mood regulation and resilience. By harnessing the brain's capacity for plasticity, ketamine therapy holds promise for transforming the landscape of depression treatment and improving outcomes for millions of individuals worldwide.

​

​